RESEARCH INTERESTs

We are recruiting PhD students!

My lab has two research areas of interest. First, we are investigating if protein degradation is a viable approach to remove cytotoxic protein aggregates commonly found in neurodgenerative disorders. Our target protein of interest is TDP-43, which upon translocation from the nucleaus to the cytosol and aggregation, possibly causes, but certainly drives pathologies of motor neuron disease (MND), esp. Amyotrophic Lateral Sclerosis (ALS), as well as frontotermporal lobar degeneration. Sceond, our lab is interested in method development of frontier mass spectrometry (MS) analysis of small molecules (both targeted and discovery metabolomics) and proteins (via intact and native MS (of protein-ligand complexs) for ligand discovery and validation.

FUNDED RESEARCH

  • GRANT
    Evaluating bacteriophage and antimicrobial peptides as novel therapies for feline urinary tract infections
    Morris Animal Foundation (USA)1 Apr 2025
    People funded by this grant:
  • GRANT
    Biodistribution of neuroprotective metal-delivering agents and relevant metals in ALS mouse brain
    Brain and Mind Centre8 Jul 2024
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    A Mass Spectrometry-Based Ligand Discovery Platform
    Charles Perkins Centre1 Jul 2024
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    Novel Ligands for TDP-43 to enable a PROTAC development platform to fight ALS
    The ALS Association1 Jan 2024
    People funded by this grant:
  • GRANT
    PROTACs for TDP-43 validated by Native Mass Spectrometry and Flow Cytometry
    Faculty of Medicine and Health1 Jan 2024
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    Labelling bacteriophages for Flow Cytometry and PET Imaging
    Sydney Institute for Infectious Diseases (Sydney ID)1 Jan 2023
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    Professional Development Award 2023
    Charles Perkins Centre1 Jan 2023
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    A PROTAC development platform against TDP-43 as a target in neurodegenerative disorders
    Centre for Drug Discovery Innovation1 Jan 2022
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    Mass Spectrometry Imaging of neuroprotective metal-chelating agents and disease-relevant metals in Parkinsonian mouse brain
    Brain and Mind Centre1 Jan 2022
    People funded by this grant:
    • Gotsbacher M
  • GRANT
    Mapping phage biodistribution and imaging infection using PET
    Sydney Institute for Infectious Diseases (Sydney ID)1 Jan 2021
    People funded by this grant:
  • GRANT
    The active and selective import of anticancer agents as a potential antibacterial mechanism
    University of Sydney1 Jan 2021
    People funded by this grant: